The value of (18)F-PSMA-1007 PET/CT in identifying non-metastatic high-risk prostate cancer

BACKGROUND: Clinical management decisions on prostate cancer (PCa) are often based on a determination of risk. (68)Ga-prostate-specific membrane antigen (PSMA)-11-positron emission tomography (PET)/computer tomography (CT) is an attractive modality to assess biochemical recurrence of PCa, detect met...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Jun-jie, Liu, Bo-le, Wang, Zhi-qiang, Tang, Kun, Ji, Xiao-wei, Yin, Wei-wei, Lin, Jie, Zheng, Xiang-wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652971/
https://www.ncbi.nlm.nih.gov/pubmed/33169183
http://dx.doi.org/10.1186/s13550-020-00730-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652971/
https://www.ncbi.nlm.nih.gov/pubmed/33169183
http://dx.doi.org/10.1186/s13550-020-00730-1

Ejemplares similares